InvestorsHub Logo
Followers 10
Posts 500
Boards Moderated 0
Alias Born 09/04/2014

Re: I.B.Broke post# 271

Saturday, 02/25/2017 4:17:09 PM

Saturday, February 25, 2017 4:17:09 PM

Post# of 1121

Corporation prepares to advance CaPre®, its krill-based omega-3 phospholipid for the treatment of patients with severe hypertriglyceridemia into a Phase 3 clinical trial.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACST News